Month: March 2025

ROSH-HA`AYIN, Israel, March 28, 2025 (GLOBE NEWSWIRE) — Kornit Digital LTD. (NASDAQ: KRNT) (“Kornit Digital” or the “Company”), a global pioneer in sustainable, on-demand digital fashion and textile production technologies, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (the “SEC”). The annual report, which contains Kornit Digital’s audited financial statements, can be accessed at the SEC’s website at http://www.sec.gov, as well as via the Company’s investor relations website at https://ir.kornit.com/financial-information/sec-filings.   The Company will provide a hard copy of its annual report on Form 20-F, including its complete audited financial statements, free of charge, to its shareholders...

SINGAPORE and SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), an AI technology company serving enterprise clients with intelligent customer communication software and services, will hold a conference call on Monday, March 31, 2025, at 4:30 p.m. Eastern Time to discuss its results for the first half of fiscal year 2025 ended December 31, 2024, ongoing initiatives, and recent milestones. A press release detailing these results will be issued prior to the call. Chief Executive Officer and Chairman Guanghai Li, and President and Interim Chief Financial Officer Amy Fong, will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations...

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with affiliates, “Base Carbon”, or the “Company”), is pleased to announce the Company will host an investor update call on Tuesday, April 1, 2025, at 11:00 a.m. Eastern Time (EDT). The Company intends to release the 2024 year-end financial results on Monday, March 31, 2025. The management team will provide a business update in connection with the results and respond to investor questions via Zoom Webinar. Registration instructions are published below. The Company invites current and prospective shareholders to attend this business update call and Q&A session. DATE: Tuesday, April 1, 2025TIME: 11:00 a.m. EDTLOCATION: Zoom Webinar. To receive...

Lexicon eligible to receive up to $1 billion in upfront and development, regulatory and sales milestone payments, including $75 million in upfront and near-term milestone payments THE WOODLANDS, Texas, March 28, 2025 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has entered into an exclusive license agreement with Novo Nordisk A/S for LX9851, a first-in-class, oral non-incretin development candidate in obesity and associated metabolic disorders. Under the terms of the agreement, Novo Nordisk obtains an exclusive, worldwide license to develop, manufacture and commercialize LX9851 in all indications. Lexicon will be responsible for completing agreed upon Investigational New Drug (IND) application-enabling activities for LX9851. Novo Nordisk will be responsible for filing the IND, all further...